Answers are grounded in this paper and cite their sources.
Patients and healthcare workers are at risk of norovirus infection. Nitazoxanide is often given, though data is lacking. Multiplex polymerase chain reaction platforms may yield false-positive results. A quality improvement initiative led to an 84.4% reduction in nitazoxanide utilization and substantial cost savings without compromising patient care or nosocomial infection.
No takes yet. Share an insight, caveat, or question.
Handley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: